162 related articles for article (PubMed ID: 22960473)
21. Cancer Stem Cell-Associated Pathways in the Metabolic Reprogramming of Breast Cancer.
El-Sahli S; Wang L
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266219
[TBL] [Abstract][Full Text] [Related]
22. Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance.
Zhou J; Wulfkuhle J; Zhang H; Gu P; Yang Y; Deng J; Margolick JB; Liotta LA; Petricoin E; Zhang Y
Proc Natl Acad Sci U S A; 2007 Oct; 104(41):16158-63. PubMed ID: 17911267
[TBL] [Abstract][Full Text] [Related]
23. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.
Cordenonsi M; Zanconato F; Azzolin L; Forcato M; Rosato A; Frasson C; Inui M; Montagner M; Parenti AR; Poletti A; Daidone MG; Dupont S; Basso G; Bicciato S; Piccolo S
Cell; 2011 Nov; 147(4):759-72. PubMed ID: 22078877
[TBL] [Abstract][Full Text] [Related]
24. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway.
Qureshi-Baig K; Kuhn D; Viry E; Pozdeev VI; Schmitz M; Rodriguez F; Ullmann P; Koncina E; Nurmik M; Frasquilho S; Nazarov PV; Zuegel N; Boulmont M; Karapetyan Y; Antunes L; Val D; Mittelbronn M; Janji B; Haan S; Letellier E
Autophagy; 2020 Aug; 16(8):1436-1452. PubMed ID: 31775562
[TBL] [Abstract][Full Text] [Related]
26. Exploring Importance and Regulation of Autophagy in Cancer Stem Cells and Stem Cell-Based Therapies.
Rahman MA; Apu EH; Rakib-Uz-Zaman SM; Chakraborti S; Bhajan SK; Taleb SA; Shaikh MH; Jalouli M; Harrath AH; Kim B
Cells; 2024 Jun; 13(11):. PubMed ID: 38891090
[TBL] [Abstract][Full Text] [Related]
27. SET Domain-Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence.
Ye S; Ding YF; Jia WH; Liu XL; Feng JY; Zhu Q; Cai SL; Yang YS; Lu QY; Huang XT; Yang JS; Jia SN; Ding GP; Wang YH; Zhou JJ; Chen YD; Yang WJ
Cancer Res; 2019 Sep; 79(18):4729-4743. PubMed ID: 31308046
[TBL] [Abstract][Full Text] [Related]
28. The role of autophagy in the cross-talk between epithelial-mesenchymal transitioned tumor cells and cancer stem-like cells.
Marcucci F; Ghezzi P; Rumio C
Mol Cancer; 2017 Jan; 16(1):3. PubMed ID: 28137290
[TBL] [Abstract][Full Text] [Related]
29. Cancer stem cells in breast: current opinion and future challenges.
Charafe-Jauffret E; Monville F; Ginestier C; Dontu G; Birnbaum D; Wicha MS
Pathobiology; 2008; 75(2):75-84. PubMed ID: 18544962
[TBL] [Abstract][Full Text] [Related]
30. Role of the IL-6-JAK1-STAT3-Oct-4 pathway in the conversion of non-stem cancer cells into cancer stem-like cells.
Kim SY; Kang JW; Song X; Kim BK; Yoo YD; Kwon YT; Lee YJ
Cell Signal; 2013 Apr; 25(4):961-9. PubMed ID: 23333246
[TBL] [Abstract][Full Text] [Related]
31. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
Oshimori N
Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
[TBL] [Abstract][Full Text] [Related]
32. PRDM14, a Zinc Finger Protein, Regulates Cancer Stemness.
Taniguchi H; Imai K
Methods Mol Biol; 2018; 1867():3-13. PubMed ID: 30155811
[TBL] [Abstract][Full Text] [Related]
33. Tipping the balance: MTDH-SND1 curbs oncogene-induced apoptosis and promotes tumorigenesis.
Kannan N; Eaves CJ
Cell Stem Cell; 2014 Aug; 15(2):118-20. PubMed ID: 25105576
[TBL] [Abstract][Full Text] [Related]
34. Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1.
Hii LW; Chung FF; Mai CW; Yee ZY; Chan HH; Raja VJ; Dephoure NE; Pyne NJ; Pyne S; Leong CO
Cells; 2020 Apr; 9(4):. PubMed ID: 32260399
[TBL] [Abstract][Full Text] [Related]
35. Autophagy is involved in TGF-β1-induced protective mechanisms and formation of cancer-associated fibroblasts phenotype in tumor microenvironment.
Liu FL; Mo EP; Yang L; Du J; Wang HS; Zhang H; Kurihara H; Xu J; Cai SH
Oncotarget; 2016 Jan; 7(4):4122-41. PubMed ID: 26716641
[TBL] [Abstract][Full Text] [Related]
36. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer.
Choi AR; Park JR; Kim RJ; Kim SR; Cho SD; Jung JY; Nam JS
Biochem Biophys Res Commun; 2012 Aug; 425(2):436-42. PubMed ID: 22846569
[TBL] [Abstract][Full Text] [Related]
38. Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cells.
Jo M; Eastman BM; Webb DL; Stoletov K; Klemke R; Gonias SL
Cancer Res; 2010 Nov; 70(21):8948-58. PubMed ID: 20940399
[TBL] [Abstract][Full Text] [Related]
39. Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.
Celià-Terrassa T; Liu DD; Choudhury A; Hang X; Wei Y; Zamalloa J; Alfaro-Aco R; Chakrabarti R; Jiang YZ; Koh BI; Smith HA; DeCoste C; Li JJ; Shao ZM; Kang Y
Nat Cell Biol; 2017 Jun; 19(6):711-723. PubMed ID: 28530657
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer stem cells: an update.
Iqbal J; Chong PY; Tan PH
J Clin Pathol; 2013 Jun; 66(6):485-90. PubMed ID: 23322821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]